Related Experiment Videos
[Renal artery angioplasty].
J M Pisco1, M O dos Santos, V M Carvalheiro
1Serviço de Radiologia, Hospital de Santa Marta, Lisboa.
Acta Medica Portuguesa
|May 1, 1992
Summary
Percutaneous transluminal angioplasty (PTA) effectively lowers blood pressure in hypertensive patients with renal artery stenosis. This renal angioplasty procedure offers a viable alternative treatment for renovascular hypertension.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Nephrology
Context:
- Renovascular hypertension affects numerous patients, often leading to difficult-to-manage blood pressure.
- Percutaneous transluminal angioplasty (PTA) is an endovascular technique used to open narrowed renal arteries.
Purpose:
- To evaluate the efficacy and outcomes of percutaneous transluminal angioplasty (PTA) in hypertensive patients with renal artery stenosis.
Summary:
- Immediate blood pressure success was observed in 91.5% of 59 patients undergoing renal artery PTA, with a sustained success rate of 79.6%.
- Better outcomes were noted in unilateral lesions (81.4%) versus bilateral (72.7%), trunk lesions (82.5%) versus ostium (71.4%), fibromuscular disease (88.9%) versus atherosclerotic (75%), and younger patients (<55 years) (84.4%) versus older (71.4%).
- While these differences were not statistically significant, the overall results support renal angioplasty as an alternative treatment.
Impact:
- The findings suggest that renal angioplasty is a valuable therapeutic option for patients suffering from renovascular hypertension.
- Successful PTA can lead to improved blood pressure control and potentially reduce cardiovascular risk in this patient population.